TITLE

Regulation of brain-derived neurotrophic factor (BDNF) during sleep apnoea treatment

AUTHOR(S)
Staats, R.; Stoll, P.; Zingler, D.; Virchow, J. C.; Lommatzsch, M.
PUB. DATE
August 2005
SOURCE
Thorax;Aug2005, Vol. 60 Issue 8, p688
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Patients with obstructive sleep apnoea syndrome (OSAS) often display persistent cognitive dysfunction despite effective treatment with continuous positive airway pressure (CPAP). Brain-derived neurotrophic factor (BDNF) is a key mediator of memory and cognition, but its regulation in OSAS and during CPAP treatment is unknown. Methods: Serum and plasma BDNF concentrations, BDNF secretion by peripheral blood mononuclear cells, and overnight polysomnography were evaluated in 17 men with newly diagnosed OSAS (as defined by a respiratory disturbance index of >10/hour with >70% obstructive events and corresponding daytime symptoms) and 12 healthy control men. In the patients all the parameters were monitored after 1 night and 3 months of CPAP treatment. Results: There was no significant difference in baseline serum BDNF, plasma BDNF, or spontaneous BDNF secretion by peripheral blood mononuclear cells between untreated patients and controls. After 1 night of CPAP treatment there was a steep fall in median serum BDNF (from 18.0 ng/ml to 4.1 ng/ml) and plasma BDNF (from 58.7 pg/ml to 22.0 pg/ml) concentrations. Following 3 months of treatment BDNF concentrations did not return to baseline. In contrast, BDNF secretion was not suppressed by CPAP treatment. Conclusions: Patients with untreated OSAS have normal serum and plasma BDNF levels. CPAP treatment is associated with a rapid decrease in serum and plasma BDNIF levels which may reflect enhanced neuronal demand for BDNF in this condition.
ACCESSION #
17967767

 

Related Articles

  • New Sleep Apnea Guidelines for Commercial Drivers. Gibb, Tamara // Pulmonary Reviews;Nov2006, Vol. 11 Issue 11, p24 

    The article discusses research being done on the screening and treatment of obstructive sleep apnea (OSA). It references a study by Nancy Collop and colleagues, published in the 2006 issue of the "Journal of Occupational and Environmental Medicine." It highlights the guidelines for the diagnosis...

  • ORTHOGNATHIC SURGERY: Surgical and Nonsurgical Management of Obstructive Sleep Apnea. Tiner, B. D.; Waite, Peter D. // Peterson's Principles of Oral & Maxillofacial Surgery;2004, Vol. 2, p1297 

    Chapter 63 of the book "Peterson's Principles of Oral and Maxillofacial Surgery" is presented. It offers an overview of the surgical and nonsurgical treatment of obstructive sleep apnea, which is a disorder characterized by abnormal breathing in sleep and fragmentation. A discussion of the...

  • Are You DEAD Tired? Kearns, Maria // Prevention;Dec2001, Vol. 53 Issue 12, p110 

    Discusses the symptoms, diagnosis, and treatment options for sleep apnea.

  • Children snoring or with sleep apnoea.  // New Zealand Doctor;9/21/2011, p50 

    The article presents guidelines for managing obstructive sleep apnea (OSA) in children, including signs and symptoms, diagnosis and treatment.

  • Ambulatory titration of continuous positive airway pressure was as effective as polysomnography for obstructive sleep apnea: COMMENTARY. Golish, Joseph; Ioachimescu, Octavian C. // ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p45 

    The article presents the authors' views on a review by A.T. Mulgrew and colleagues of the research that suggested the similarity in the effect of ambulatory titration of continuous positive airway pressure and polysomnography in the treatment of obstructive sleep apnea. It is viewed that about...

  • GOOD CARE & SERVICE. Marshall-Hare, Donna // Edmontonians;Jun2011, Vol. 22 Issue 2, p34 

    The article offers brief information on Continuous positive airway pressure (CPAP), a treatment for Obstructive Sleep Apnea (OSA), provided by Sleep Therapeutics.

  • The feasibility of using auto-titrating continuous positive airway pressure to treat obstructive sleep apnoea after acute tetraplegia. Berlowitz, D. J.; Spong, Jo; Pierce, R. J.; Ross, J.; Barnes, M.; Brown, D. J. // Spinal Cord;Dec2009, Vol. 47 Issue 12, p868 

    Study design:A prospective cohort with acute tetraplegia.Objectives:Obstructive sleep apnoea (OSA) is common within weeks of tetraplegia. This study aimed at determining the feasibility of auto-titrating continuous positive airway pressure (CPAP) to treat OSA after acute tetraplegia.Setting:The...

  • MED-TECH NEWS AND NOTES.  // Diagnostics & Imaging Week;12/24/2008, Vol. 11 Issue 51, p12 

    The article reports on the launch of Sandman Alliance, a sleep therapy management program of Covidien. The program is an addition to the United to Treat Sleep Apnea initiative of the company which aimed to improve the diagnosis and treatment of sleep disorders. The program is composed of...

  • Diagnosis and Treatment of Sleep Apnea Can Help Prolong Your Life.  // Healthy Years;May2013, Vol. 10 Issue 5, p1 

    The article discusses the diagnosis and treatment of obstructive sleep apnea (OSA), a condition that affects a person's quality of sleep and raises their risks of numerous health problems. Some of the symptoms of OSA include daytime sleepiness, fatigue and non-restorative sleep. It describes a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics